Somapacitan
Sogroya (somapacitan) is a small molecule pharmaceutical. Somapacitan was first approved as Sogroya on 2021-03-31. It has been approved in Europe to treat growth.
| Trade Name | Sogroya |
|---|---|
| Common Name | Somapacitan |
| Indication | growth |
| Drug Class | Growth hormone derivatives |
